Company Description
The company is engaged in the production and marketing of medicines, cosmetics and food supplements, and also holds a franchise for the distribution of Mifal HaPais products.
Important Data and Indicators
In millions of NIS (rounded). Earnings per share in NIS.
[gswpts_table id=”115″]
5-year stock chart
– Stock chart – 30-day average – Average 200 days
Main stakeholders
Data from Q2:
Revenues amounted to NIS 67 million, profit to NIS (0.5) million, and earnings per share to NIS 0. This means a 5% increase in sales, a shift from profit to loss in profit, and a shift from profit to loss in earnings per share, compared to the same period last year.
Editor’s recommendation:
This is not a substitute for investment advice by an investment advisor licensed by law that takes into account the special needs of each person. The authors of this review may own or sell financial assets of the company under review, and the authors may have an interest in the companies mentioned.
